Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Immunotherapy, Adoptive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02215967
What this trial is testing

Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma

Who this might be right for
Myeloma, Plasma-CellMyeloma-Multiple
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00005606
What this trial is testing

Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Northwestern University
Not applicableEnded earlyNCT00000824
What this trial is testing

Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)UnknownNCT03977103
What this trial is testing

Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMyeloproliferative Disorders+3 more
University Of Perugia 80
Early research (Phase 1)Looking for participantsNCT03326921
What this trial is testing

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Who this might be right for
Juvenile Myelomonocytic LeukemiaRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Undifferentiated Leukemia+26 more
Fred Hutchinson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT01326104
What this trial is testing

Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor

Who this might be right for
MedulloblastomaNeuroectodermal Tumor
University of Florida 26
Testing effectiveness (Phase 2)WithdrawnNCT00159055
What this trial is testing

Adoptive Immunotherapy for CMV Disease

Who this might be right for
CMV Disease
Hadassah Medical Organization 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155191
What this trial is testing

Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Lymphoblastic Leukemia, Acute Adult
Takara Bio Inc. 21
Testing effectiveness (Phase 2)Study completedNCT01740557
What this trial is testing

Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma

Who this might be right for
Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7
M.D. Anderson Cancer Center 10
Very early researchLooking for participantsNCT07261657
What this trial is testing

N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

Who this might be right for
Myxoid LiposarcomaRound Cell LiposarcomaSynovial Sarcoma
Seth Pollack 8
Testing effectiveness (Phase 2)Ended earlyNCT02379442
What this trial is testing

Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids

Who this might be right for
Graft-Versus-Host Disease
National Heart, Lung, and Blood Institute (NHLBI) 1
Very early researchLooking for participantsNCT02982902
What this trial is testing

T Cell Therapy of Opportunistic Cytomegalovirus Infection

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell TransplantOpportunistic Infections
Mari Dallas 20
Large-scale testing (Phase 3)Looking for participantsNCT05727904
What this trial is testing

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Who this might be right for
Metastatic MelanomaUnresectable MelanomaMelanoma
Iovance Biotherapeutics, Inc. 670
Early research (Phase 1)UnknownNCT00799799
What this trial is testing

Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells

Who this might be right for
Myeloblastic Leukemia
University of Bologna 15
Early research (Phase 1)Study completedNCT03448393
What this trial is testing

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

Who this might be right for
Lymphoma, Non-HodgkinLeukemia, Lymphocytic, B CellB-Cell Lymphoma+7 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Ended earlyNCT01468818
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 18
Early research (Phase 1)UnknownNCT01793025
What this trial is testing

Mismatched Donor Cells to Treat Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Maisonneuve-Rosemont Hospital 12
Very early researchUnknownNCT03790891
What this trial is testing

Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Who this might be right for
Non-Hodgkin Lymphoma
Timmune Biotech Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06557265
What this trial is testing

NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Who this might be right for
Lupus NephritisPrimary Membranous Nephropathy
Nkarta, Inc. 120
Early research (Phase 1)Ended earlyNCT02188719
What this trial is testing

Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation

Who this might be right for
Liver Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 15
Next Page